New simulation tool expands the range of eligible trials. By Deb Borfitz November 16, 2010 | The first upgrade to a one of a kind simulation tool co developed by Tessella and Berry Consultants significantly enlarges the proportion of clinical

Nov 15 | eCliniqua | Expert Commentary | An exciting recent advance in medicine has been the generation of induced pluripotent stem (iPS) cells which are derived from somatic cells, rather than embryos, through a process of “de-differentiation.” But the advance raises important intellectual property and patent questions.

Nov 15 | eCliniqua | BRISBANE—At TRX10, Translational Research Excellence, held last month in Brisbane, amid a wide-ranging program covering everything from stem cell models to commercializing academic innovations, translational approaches to cancer and central nervous system disease to trial design, discussion turned to repositories for genetic and clinical data. Researchers encouraged one another to share raw data, analyses, and clinical findings to further research and enable advances in medicine.

Nov 11 | News Brief | Covance has closed its transactions with sanofi-aventis to become its R&D partner over the next 10 years and to purchase sanofi-aventis' Porcheville, France and Alnwick, United Kingdom sites.

Nov 8 | News Brief | Perceptive Informatics has incorporated IBM's WebSphere portal and Tivoli Access Manager into its eClinical platform, which provides support for its eClinical Suite.

Nov 5 | News Brief | The Site Solutions Summit, an annual conference of premier clinical research sites from around the world, voted to present their 2010 Site Solutions Summit Eagle Awards to Eli Lilly and Company, as the top pharmaceutical firm, and PPD, as the top contract research organization (CRO).

Nov 1 | News & Observer | Joseph Nevins, a professor and director of Duke's Center for Applied Genomics and Technology, has asked that the Journal of Clinical Oncology retract work finding a genetic link to cancer patients' drug response that he submitted with a colleague in 2007.

Oct 18 | News Brief | BioClinica has signed a three-year, multi-million dollar agreement for enterprise-wide EDC technology and data management services with a global, multibillion dollar division of a Top 10 pharmaceutical company.

Oct 18 | News Brief | HUYA Bioscience International and Quintiles have announced an agreement to co-develop a new cancer drug, HBI-8000, sourced in China by HUYA.

Oct 18 | eClinica | The first upgrade to a one-of-a-kind simulation tool co-developed by Tessella and Berry Consultants significantly enlarges the proportion of clinical studies that can benefit from simulation of the design.

Sept 24 | News Brief | The National eHealth Collaborative (NeHC) has announced the course schedule for the Fall 2010 semester of Nationwide Health Information Network (NHIN) University.

Sept 22 | News Brief | Ariana Pharma and the US Food and Drug Administration (FDA) have entered into a partnership. Ariana Pharma is providing its KEM Biomarker technology to help enable FDA reviewers to analyze pharmacogenomic data combined with patient characteristics for biomarker signatures

Sept 21 | eCliniqua | If clinical trial data were sourced electronically rather than on paper, pharmaceutical companies could reap huge savings—most notably by eliminating site monitoring for purposes of source data verification (SDV). Yet e-sourcing remains a relatively rare practice, in part because sites find it inconvenient to enter data directly into electronic data capture (EDC) systems.